Dendritic cell-mediated T cell polarization

Effective defense against diverse types of micro-organisms that invade our body requires specialized classes of antigen-specific immune responses initiated and maintained by distinct subsets of effector CD4+ T helper (Th) cells. Excessive or detrimental (e.g., autoimmune) responses by effector T cells are controlled by regulatory T cells. The optimal balance in the development of the different types of effector and regulatory Th cells is orchestrated by dendritic cells (DC). This review discusses the way DC adapt the T cell response to the type of pathogen, focusing on the tools that DC use in this management of the T cell response.

[1]  Michel C Nussenzweig,et al.  Tolerogenic dendritic cells. , 2003, Annual review of immunology.

[2]  V. Verhasselt,et al.  Dendritic cells exposed to nacystelyn are refractory to maturation and promote the emergence of alloreactive regulatory T cells , 2003, Transplantation.

[3]  Robert V Farese,et al.  Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. , 1997, The Journal of clinical investigation.

[4]  J. Bluestone,et al.  Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. , 1995, Immunity.

[5]  Shizuo Akira,et al.  Innate Antiviral Responses by Means of TLR7-Mediated Recognition of Single-Stranded RNA , 2004, Science.

[6]  G. Kollias,et al.  Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8+ T cell tolerance. , 2003, Immunity.

[7]  D. Roberts,et al.  Malaria, monocytes, macrophages and myeloid dendritic cells: sticking of infected erythrocytes switches off host cells. , 2002, Current opinion in immunology.

[8]  C. Akdis,et al.  IL‐10 directly acts on T cells by specifically altering the CD28 co‐stimulation pathway , 2000, European journal of immunology.

[9]  R. de Waal Malefyt,et al.  IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells. , 2001, Journal of immunology.

[10]  T. Giese,et al.  Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. , 2001, European journal of immunology.

[11]  G. Trinchieri,et al.  Interleukin-12 and the regulation of innate resistance and adaptive immunity , 2003, Nature Reviews Immunology.

[12]  P. Rogers,et al.  OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. , 2001, Immunity.

[13]  H. Griesser,et al.  Lymphoproliferative Disorders with Early Lethality in Mice Deficient in Ctla-4 , 1995, Science.

[14]  Katsuaki Sato,et al.  Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. , 2003, Blood.

[15]  P. Kalinski,et al.  Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells. , 1999, Journal of immunology.

[16]  T. Mcclanahan,et al.  IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. , 2002, Immunity.

[17]  J. Lamb,et al.  Serrate1-induced notch signalling regulates the decision between immunity and tolerance made by peripheral CD4(+) T cells. , 2000, International immunology.

[18]  P. Kalinski,et al.  Corticosteroids inhibit the production of inflammatory mediators in immature monocyte‐derived DC and induce the development of tolerogenic DC3 , 1999, Journal of leukocyte biology.

[19]  H. Smits,et al.  Intercellular Adhesion Molecule-1/LFA-1 Ligation Favors Human Th1 Development1 , 2002, The Journal of Immunology.

[20]  武田 篤信.  Cutting edge : Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment , 2003 .

[21]  A. Enk,et al.  Induction of tolerance by IL-10-treated dendritic cells. , 1997, Journal of immunology.

[22]  K. Mills,et al.  Pathogen-specific T Regulatory 1 Cells Induced in the Respiratory Tract by a Bacterial Molecule that Stimulates Interleukin 10 Production by Dendritic Cells , 2002, The Journal of experimental medicine.

[23]  M. Roncarolo,et al.  The Role of IL-10 and TGF-β in the Differentiation and Effector Function of T Regulatory Cells , 2002, International Archives of Allergy and Immunology.

[24]  C Caux,et al.  Immunobiology of dendritic cells. , 2000, Annual review of immunology.

[25]  G. Zhu,et al.  B7-H3: A costimulatory molecule for T cell activation and IFN-γ production , 2001, Nature Immunology.

[26]  L. Fabbri,et al.  Antibodies to the IL-12 receptor beta 2 chain mark human Th1 but not Th2 cells in vitro and in vivo. , 1999, Journal of immunology.

[27]  A. Maroof,et al.  Retrovirally induced switch from production of IL‐12 to IL‐4 in dendritic cells , 1999, European journal of immunology.

[28]  Marc Dalod,et al.  Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology , 2001, Nature Immunology.

[29]  N. Gay,et al.  Structural Complementarity of Toll/Interleukin-1 Receptor Domains in Toll-like Receptors and the Adaptors Mal and MyD88* , 2003, Journal of Biological Chemistry.

[30]  R. Kastelein,et al.  Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain , 2003, Nature.

[31]  P. Kalinski,et al.  Development of Th1-Inducing Capacity in Myeloid Dendritic Cells Requires Environmental Instruction1 , 2000, The Journal of Immunology.

[32]  J. Allison,et al.  BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1 , 2003, Nature Immunology.

[33]  B. Rollins,et al.  Monocyte Chemoattractant Protein‐1 (CCL2) in Inflammatory Disease and Adaptive Immunity: Therapeutic Opportunities and Controversies , 2003, Microcirculation.

[34]  J. Bluestone,et al.  LFA-1 interaction with ICAM-1 and ICAM-2 regulates Th2 cytokine production. , 1998, Journal of immunology.

[35]  E. Schmitt,et al.  IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. , 1998, Journal of immunology.

[36]  P. Amrolia,et al.  Overexpression of the Notch ligand, Jagged-1, induces alloantigen-specific human regulatory T cells. , 2003, Blood.

[37]  M. Bachmann,et al.  OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL Responses after virus infection. , 1999, Immunity.

[38]  G. Freeman,et al.  Ox40-ligand has a critical costimulatory role in dendritic cell:T cell interactions. , 1999, Immunity.

[39]  M. Kaplan,et al.  Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice , 1996, Nature.

[40]  W. Ouyang,et al.  Signaling and transcription in T helper development. , 2000, Annual review of immunology.

[41]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[42]  T. Mak,et al.  The IL-27R (WSX-1) is required to suppress T cell hyperactivity during infection. , 2003, Immunity.

[43]  Manfred Brockhaus,et al.  A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing , 1997, The Journal of experimental medicine.

[44]  S. Akira,et al.  Microbial Recognition Via Toll-Like Receptor-Dependent and -Independent Pathways Determines the Cytokine Response of Murine Dendritic Cell Subsets to CD40 Triggering1 , 2002, The Journal of Immunology.

[45]  E. Kieff,et al.  A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes , 1996, Journal of virology.

[46]  L. Adorini,et al.  Regulatory T Cells Induced by 1α,25-Dihydroxyvitamin D3 and Mycophenolate Mofetil Treatment Mediate Transplantation Tolerance1 , 2001, The Journal of Immunology.

[47]  M. Kapsenberg.  Dendritic-cell control of pathogen-driven T-cell polarization , 2003, Nature Reviews Immunology.

[48]  Klaus Eichmann,et al.  Murine Macrophages Secrete Interferon γ upon Combined Stimulation with Interleukin (IL)-12 and IL-18: A Novel Pathway of Autocrine Macrophage Activation , 1998, The Journal of experimental medicine.

[49]  C. Martínez-A,et al.  The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness , 1998, The Journal of experimental medicine.

[50]  Katsuaki Sato,et al.  Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse. , 2003, Immunity.

[51]  T. Standiford,et al.  Adenoviral-Mediated Overexpression of Monocyte Chemoattractant Protein-1 Differentially Alters the Development of Th1 and Th2 Type Responses In Vivo1 , 2000, The Journal of Immunology.

[52]  M. Neurath,et al.  Cutting Edge: IL-12 and IL-18 Differentially Regulate the Transcriptional Activity of the Human IFN-γ Promoter in Primary CD4+ T Lymphocytes , 1998, The Journal of Immunology.

[53]  Antonio Lanzavecchia,et al.  Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells , 2001, European journal of immunology.

[54]  O. Majdic,et al.  B7-H1 (Programmed Death-1 Ligand) on Dendritic Cells Is Involved in the Induction and Maintenance of T Cell Anergy 1 , 2003, The Journal of Immunology.

[55]  P. Kalinski,et al.  T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal. , 1999, Immunology today.

[56]  M. Jordana,et al.  The B7 family member B7-H3 preferentially down-regulates T helper type 1–mediated immune responses , 2003, Nature Immunology.

[57]  T. Aoki,et al.  Critical Contribution of Ox40 Ligand to T Helper Cell Type 2 Differentiation in Experimental Leishmaniasis , 2000, The Journal of experimental medicine.

[58]  T. Okazaki,et al.  Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. , 2001, Science.

[59]  S. Kunkel,et al.  Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. , 1996, Journal of immunology.

[60]  P. Lenz,et al.  IL-23 Production by Cosecretion of Endogenous p19 and Transgenic p40 in Keratin 14/p40 Transgenic Mice: Evidence for Enhanced Cutaneous Immunity , 2003, The Journal of Immunology.

[61]  R. de Waal Malefyt,et al.  IFN-α and IL-10 Induce the Differentiation of Human Type 1 T Regulatory Cells1 , 2001, The Journal of Immunology.

[62]  CD4+ T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens. , 1997, Journal of immunology.

[63]  J. Bach.  Regulatory lymphocytes: Regulatory T cells under scrutiny , 2003, Nature Reviews Immunology.

[64]  A. Nash,et al.  The role of endogenous interleukin-12 in resistance to murine cytomegalovirus (MCMV) infection and a novel action for endogenous IL-12 p40. , 1999, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[65]  M. Neurath,et al.  Disruption of T helper 2-immune responses in Epstein–Barr virus-induced gene 3-deficient mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[66]  A. Sher,et al.  Single Cell Analysis Reveals That IL-4 Receptor/Stat6 Signaling Is Not Required for the In Vivo or In Vitro Development of CD4+ Lymphocytes with a Th2 Cytokine Profile , 2000, The Journal of Immunology.

[67]  D. Pardoll,et al.  B7-Dc, a New Dendritic Cell Molecule with Potent Costimulatory Properties for T Cells , 2001, The Journal of experimental medicine.

[68]  S. Dower,et al.  IL-1Rrp Is a Novel Receptor-like Molecule Similar to the Type I Interleukin-1 Receptor and Its Homologues T1/ST2 and IL-1R AcP (*) , 1996, The Journal of Biological Chemistry.

[69]  G. Freeman,et al.  Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation , 2000, The Journal of experimental medicine.

[70]  T. Honjo,et al.  Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. , 1998, International immunology.

[71]  G. Rook,et al.  Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells , 2002, Nature Medicine.

[72]  S. Akira,et al.  Defective NK cell activity and Th1 response in IL-18-deficient mice. , 1998, Immunity.

[73]  J. Bluestone,et al.  CD28/B7 system of T cell costimulation. , 1996, Annual review of immunology.

[74]  T. Honjo,et al.  Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. , 1999, Immunity.

[75]  H. Weiner,et al.  IL‐4 is a differentiation factor for transforming growth factor‐β secreting Th3 cells and oral administration of IL‐4 enhances oral tolerance in experimental allergic encephalomyelitis , 1998, European journal of immunology.

[76]  B. Haagmans,et al.  Mice lacking IL-12 develop polarized Th1 cells during viral infection. , 1998, Journal of immunology.

[77]  W. Kuziel,et al.  CCR2 Expression Determines T1 Versus T2 Polarization During Pulmonary Cryptococcus neoformans Infection1 , 2000, The Journal of Immunology.

[78]  G. Freeman,et al.  PD-L2 is a second ligand for PD-1 and inhibits T cell activation , 2001, Nature Immunology.

[79]  C. Dong,et al.  B7S1, a novel B7 family member that negatively regulates T cell activation. , 2003, Immunity.

[80]  J. de Maeyer-Guignard,et al.  Type I interferons. , 1998, International reviews of immunology.

[81]  L Adorini,et al.  The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. , 1998, Annual review of immunology.

[82]  G. Zhu,et al.  B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. , 2003, Immunity.

[83]  Sami Al-Hajjar,et al.  Low Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor β1 Deficiency , 2003, The Journal of Experimental Medicine.

[84]  M. Noris,et al.  Natural versus adaptive regulatory T cells. , 2005, Contributions to nephrology.

[85]  D. Mancini,et al.  High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. , 2003, Transplant immunology.

[86]  C. Benoist,et al.  The Dendritic Cell Populations of Mouse Lymph Nodes1 , 2001, The Journal of Immunology.

[87]  T. Mcclanahan,et al.  A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R1 , 2002, The Journal of Immunology.

[88]  H. Smits,et al.  IL-4 Is a Mediator of IL-12p70 Induction by Human Th2 Cells: Reversal of Polarized Th2 Phenotype by Dendritic Cells1 , 2000, The Journal of Immunology.

[89]  G. Zhu,et al.  B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. , 2001, Nature immunology.

[90]  M. Croft.  Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? , 2003, Nature Reviews Immunology.

[91]  Sami Al-Hajjar,et al.  Low penetrance, broad resistance, and favorable outcome of interleukin 12 receptor beta1 deficiency: medical and immunological implications. , 2003, The Journal of experimental medicine.

[92]  C. Albanesi,et al.  Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. , 2000, The Journal of investigative dermatology.

[93]  G. Trinchieri,et al.  The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. , 2003, Immunity.

[94]  岡崎 拓.  PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine , 2003 .

[95]  T. Honjo,et al.  Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. , 1996, International immunology.

[96]  T. Mcclanahan,et al.  WSX-1 and Glycoprotein 130 Constitute a Signal-Transducing Receptor for IL-27 , 2004, The Journal of Immunology.

[97]  G. V. van Seventer,et al.  Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development. , 1998, Journal of immunology.

[98]  P. Doherty,et al.  Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells , 1996, Nature.

[99]  S. Kunkel,et al.  Monocyte Chemotactic Protein 1 Regulates Oral Tolerance Induction by Inhibition of T Helper Cell 1–related Cytokines , 1998, The Journal of experimental medicine.

[100]  K. MacDonald,et al.  Characterization of human blood dendritic cell subsets. , 2002, Blood.

[101]  B. Rollins,et al.  Abnormalities in Monocyte Recruitment and Cytokine Expression in Monocyte Chemoattractant Protein 1–deficient Mice , 1998, The Journal of experimental medicine.

[102]  T. Mak,et al.  WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. , 2001, Immunity.

[103]  S. Akira,et al.  Regulation of dendritic cell function through toll-like receptors. , 2003, Current molecular medicine.

[104]  N. Willcox,et al.  A role for CD36 in the regulation of dendritic cell function , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[105]  T. Luft,et al.  Interleukin (Il)-4 Is a Major Regulatory Cytokine Governing Bioactive IL-12 Production by Mouse and Human Dendritic Cells , 2000, The Journal of experimental medicine.

[106]  M. Colonna,et al.  Tolerization of dendritic cells by TS cells: the crucial role of inhibitory receptors ILT3 and ILT4 , 2002, Nature Immunology.

[107]  N. Kadowaki,et al.  Natural Interferon α/β–Producing Cells Link Innate and Adaptive Immunity , 2000, The Journal of experimental medicine.

[108]  T. Honjo,et al.  Induced expression of PD‐1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. , 1992, The EMBO journal.

[109]  P. Kalinski,et al.  High-level IL-12 production by human dendritic cells requires two signals. , 1998, International immunology.

[110]  J Wagner,et al.  Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. , 2000, Immunity.

[111]  C. Figdor,et al.  Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression , 1991, The Journal of experimental medicine.

[112]  F.J. Sauvage,et al.  Development of Th1-type immune responses requires the type I cytokine receptor TCCR , 2000, Nature.

[113]  Yuetsu Tanaka,et al.  Expression and function of OX40 ligand on human dendritic cells. , 1997, Journal of immunology.

[114]  S. Dzik.  B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin 10 secretion , 2000 .

[115]  Yuetsu Tanaka,et al.  Microbial Compounds Selectively Induce Th1 Cell-Promoting or Th2 Cell-Promoting Dendritic Cells In Vitro with Diverse Th Cell-Polarizing Signals1 , 2002, The Journal of Immunology.

[116]  J. Brouwers,et al.  A Novel Host-Parasite Lipid Cross-talk , 2002, The Journal of Biological Chemistry.

[117]  P. Ricciardi-Castagnoli,et al.  Dendritic Cells Discriminate between Yeasts and Hyphae of the Fungus Candida albicans , 2000, The Journal of experimental medicine.

[118]  H. Smits,et al.  Commensal Gram‐negative bacteria prime human dendritic cells for enhanced IL‐23 and IL‐27 expression and enhanced Th1 development , 2004, European journal of immunology.

[119]  G. Zhu,et al.  B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. , 2004, Immunity.

[120]  T. Mcclanahan,et al.  Divergent Pro- and Antiinflammatory Roles for IL-23 and IL-12 in Joint Autoimmune Inflammation , 2003, The Journal of experimental medicine.

[121]  M. Colonna,et al.  A novel family of Ig‐like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells , 1999, Journal of leukocyte biology.

[122]  Hervé Groux,et al.  A CD4+T-cell subset inhibits antigen-specific T-cell responses and prevents colitis , 1997, Nature.

[123]  Ilkka Julkunen,et al.  Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response1 , 2001, The Journal of Immunology.

[124]  Lieping Chen,et al.  Cooperative B7-1/2 (CD80/CD86) and B7-DC Costimulation of CD4+ T Cells Independent of the PD-1 Receptor , 2003, The Journal of experimental medicine.

[125]  S. Akira,et al.  Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8 , 2004, Science.

[126]  R. Zinkernagel,et al.  IL-12 is not required for induction of type 1 cytokine responses in viral infections. , 1999, Journal of immunology.

[127]  M. Kamoun,et al.  Induction of Experimental Autoimmune Encephalomyelitis in IL-12 Receptor-β2-Deficient Mice: IL-12 Responsiveness Is Not Required in the Pathogenesis of Inflammatory Demyelination in the Central Nervous System1 , 2003, The Journal of Immunology.

[128]  N. Kadowaki,et al.  Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens , 2001, The Journal of experimental medicine.

[129]  M. Jackson,et al.  Intercellular adhesion molecule-1 inhibits interleukin 4 production by naive T cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[130]  A. Enk,et al.  Induction of Interleukin 10–Producing, Nonproliferating Cd4+ T Cells with Regulatory Properties by Repetitive Stimulation with Allogeneic Immature Human Dendritic Cells , 2000, The Journal of experimental medicine.

[131]  K. Toellner,et al.  CD4 T Cell Cytokine Differentiation: The B Cell Activation Molecule, OX40 Ligand, Instructs CD4 T Cells to Express Interleukin 4 and Upregulates Expression of the Chemokine Receptor, Blr-1 , 1998, The Journal of experimental medicine.

[132]  G. Ogg,et al.  Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. , 1998, Journal of immunology.

[133]  H. Weiner,et al.  Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. , 1996, The Journal of clinical investigation.

[134]  D. Cantrell,et al.  Sustained IL-12 Signaling Is Required for Th1 Development 1 , 2004, The Journal of Immunology.

[135]  K. Shortman,et al.  Dendritic cell subtypes in mouse lymphoid organs: cross-correlation of surface markers, changes with incubation, and differences among thymus, spleen, and lymph nodes. , 1997, Journal of immunology.

[136]  T. Mak,et al.  WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. , 2003, Immunity.